Kanger in MoU with Zuellig


Kanger’s executive director Steven Kuah Choon Ching (pic) said in a press release that the company is pleased to be in this MOU to facilitate the distribution of Sinopharm’s Covid-19 vaccines in Malaysia.

PETALING JAYA: ACE Market-listed Kanger International Bhd has entered into a memorandum of understanding (MoU) with Zuellig Pharma Sdn Bhd for Covid-19 vaccine distribution in Malaysia.

Zuellig Pharma is one of the license holders authorised by the Malaysian Government to handle the distribution of vaccines.

Kanger’s executive director Steven Kuah Choon Ching (pic) said in a press release that the company is pleased to be in this MOU to facilitate the distribution of Sinopharm’s Covid-19 vaccines in Malaysia.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

83% readers found this article insightful

Next In Business News

TDM says CEO Zainal Abidin resigned over disagreement with chairman�
Petronas posts RM3.4bil net loss in Q3
Boustead appoints former Telekom boss Shazalli Ramly as new Group MD
Public Bank 3Q net profit higher at RM1.39b
CIMB's 3Q pre-tax profit improves sequentially on higher operating income
Kenanga IB profit up tenfold as brokerage, trading income soar
Palm oil’s stunning rally is set to boost supermarket prices
Alliance Bank posts lower 2Q net profit of RM103.94m on higher reserves
Pandemic and travel curbs hit Datasonic Q2 earnings�
Higher net profit for Hong Leong Bank

Stories You'll Enjoy